What's Happening With Sonnet BioTherapeutics Stock?

What's Happening With Sonnet BioTherapeutics Stock?
  • Trading of Sonnet BioTherapeutics Holdings Inc SONN stock was halted thrice during the early morning session.
  • No company-specific reports are driving up the stock price today, so it appears there are external factors at play.
  • Discussions about Sonnet have floated on social media platforms like StockTwits, Twitter, and Discord. 
  • Investors on these platforms are citing the Company as being a short squeeze candidate. 
  • The clinical-stage biotech company focused on cancer therapeutics reported its Q3 FY21 results early this week. 
  • Price Action: SONN shares are up 151.0% at $1.87 during the market session on the last check Thursday.

Posted In: BriefsoncologyBiotechLong IdeasNewsPenny StocksHealth CareMoversTrading IdeasGeneral